IRCT20210831052351N1招募中3 期
Evaluation of efficacy of celecoxib as add on to risperidone to reduce positive , negative and cognitive symptoms in schizophrenic patients in active phase: a double-blind, randomized and placebo-controlled clinical trial
niversity of social welfare and rehabilitation sciences0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Patients with schizophrenia in the acute phase
- •Age range 18 to 65 years
- •Receiving only one Antipsychotic drug (Risperidone)
- •IQ greater than 70
- •Having the consent of the patient and his / her guardian to participate in the research
排除标准
- •Having a debilitating physical illness
- •patients with depression
- •Received an electric shock in the last two weeks
- •History of gastric ulcer or acute gastric bleeding
- •Pregnancy and lactation
- •No extra pyramidal symptoms in the study entry based on Simpson-Angus scale
- •Drug, alcohol or drug abuse in the last 6 months (excluding nicotine)
- •There is another diagnosis based on DSM5, including mood disorders and mental retardation
- •Blindness and deafness
研究者
相似试验
已完成
2 期
Efficacy of celecoxib in the treatment of bipolar disorderIRCT201307171556N53Tehran University of Medical Sciences50
招募中
Unknown
Evaluating the effect of celecoxib in comparison with acetaminophen on orthodontic pain managementIRCT20221109056454N1Tehran University of Medical Sciences70
已完成
2 期
Efficacy of adjunctive Celecoxib in improvement of Obsessive-compulsive disorderObsessive-compulsive disorder.Obsessive-compulsive disorderIRCT201512235280N21Vice chancellor for research of Mashhad University of Medical Sciences40
招募中
3 期
Effects of add-on Celecoxib treatment in patients with schizophrenia spectrum disorders and inflammatory cytokine profile (TargetFlame)Schizophrenie oder schizophrene Spektrum-erkrankungF20SchizophreniaDRKS00029044Bezirkskliniken Schwaben109
招募中
1 期
Effects of add-on Celecoxib treatment in patients with schizophrenia spectrum disorders and inflammatory cytokine profile (TargetFlame)SchizophreniaEUCTR2021-002572-39-DEBezirkskliniken Schwaben109